| Literature DB >> 31791841 |
Maryam A Hejazi1, Wei Tong2, Alastair Stacey1, Artemio Soto-Breceda3, Michael R Ibbotson4, Molis Yunzab5, Matias I Maturana6, Ali Almasi5, Young Jun Jung4, Shi Sun4, Hamish Meffin7, Jian Fang8, Melanie E M Stamp1, Kumaravelu Ganesan1, Kate Fox9, Aaqil Rifai10, Athavan Nadarajah1, Samira Falahatdoost1, Steven Prawer1, Nicholas V Apollo11, David J Garrett12.
Abstract
Implantable medical devices are now in regular use to treat or ameliorate medical conditions, including movement disorders, chronic pain, cardiac arrhythmias, and hearing or vision loss. Aside from offering alternatives to pharmaceuticals, one major advantage of device therapy is the potential to monitor treatment efficacy, disease progression, and perhaps begin to uncover elusive mechanisms of diseases pathology. In an ideal system, neural stimulation, neural recording, and electrochemical sensing would be conducted by the same electrode in the same anatomical region. Carbon fiber (CF) microelectrodes are the appropriate size to achieve this goal and have shown excellent performance, in vivo. Their electrochemical properties, however, are not suitable for neural stimulation and electrochemical sensing. Here, we present a method to deposit high surface area conducting diamond on CF microelectrodes. This unique hybrid microelectrode is capable of recording single-neuron action potentials, delivering effective electrical stimulation pulses, and exhibits excellent electrochemical dopamine detection. Such electrodes are needed for the next generation of miniaturized, closed-loop implants that can self-tune therapies by monitoring both electrophysiological and biochemical biomarkers.Entities:
Keywords: Biosensing; Carbon fiber; Diamond; Neural interface; Neural stimulation; Recording
Mesh:
Substances:
Year: 2019 PMID: 31791841 DOI: 10.1016/j.biomaterials.2019.119648
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479